Subjects were randomized into 4 cohorts : 800 mg of 744 LA intramuscularly ( IM ) followed by 3 monthly doses of ( 1 ) 200 mg subcutaneously , ( 2 ) 200 mg IM , ( 3 ) 400 mg IM , or ( 4 ) a second injection of 800 mg IM after 12 weeks .